BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27080984)

  • 1. PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for active surveillance.
    Trock BJ; Fedor H; Gurel B; Jenkins RB; Knudsen BS; Fine SW; Said JW; Carter HB; Lotan TL; De Marzo AM
    Mod Pathol; 2016 Jul; 29(7):764-71. PubMed ID: 27080984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTEN loss is associated with upgrading of prostate cancer from biopsy to radical prostatectomy.
    Lotan TL; Carvalho FL; Peskoe SB; Hicks JL; Good J; Fedor H; Humphreys E; Han M; Platz EA; Squire JA; De Marzo AM; Berman DM
    Mod Pathol; 2015 Jan; 28(1):128-137. PubMed ID: 24993522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.
    Yoshimoto M; Ding K; Sweet JM; Ludkovski O; Trottier G; Song KS; Joshua AM; Fleshner NE; Squire JA; Evans AJ
    Mod Pathol; 2013 Mar; 26(3):435-47. PubMed ID: 23018874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of 8p is an independent prognostic parameter in prostate cancer.
    Kluth M; Amschler NN; Galal R; Möller-Koop C; Barrow P; Tsourlakis MC; Jacobsen F; Hinsch A; Wittmer C; Steurer S; Krech T; Büscheck F; Clauditz TS; Beyer B; Wilczak W; Graefen M; Huland H; Minner S; Schlomm T; Sauter G; Simon R
    Oncotarget; 2017 Jan; 8(1):379-392. PubMed ID: 27880722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN Loss in Gleason Score 3 + 4 = 7 Prostate Biopsies is Associated with Nonorgan Confined Disease at Radical Prostatectomy.
    Guedes LB; Tosoian JJ; Hicks J; Ross AE; Lotan TL
    J Urol; 2017 Apr; 197(4):1054-1059. PubMed ID: 27693448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of the genomic instability of PTEN in clinically insignificant and significant prostate cancer.
    Murphy SJ; Karnes RJ; Kosari F; Castellar BE; Kipp BR; Johnson SH; Terra S; Harris FR; Halling GC; Klein JL; Nasir A; Bergstrahl E; Rangel LJ; Sukov WR; Vasmatzis G; Cheville JC
    Mod Pathol; 2016 Feb; 29(2):143-56. PubMed ID: 26612463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer.
    Troyer DA; Jamaspishvili T; Wei W; Feng Z; Good J; Hawley S; Fazli L; McKenney JK; Simko J; Hurtado-Coll A; Carroll PR; Gleave M; Lance R; Lin DW; Nelson PS; Thompson IM; True LD; Brooks JD; Squire JA
    Prostate; 2015 Aug; 75(11):1206-15. PubMed ID: 25939393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations.
    Gandellini P; Casiraghi N; Rancati T; Benelli M; Doldi V; Romanel A; Colecchia M; Marenghi C; Valdagni R; Demichelis F; Zaffaroni N
    Eur Urol Oncol; 2019 May; 2(3):277-285. PubMed ID: 31200842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer.
    El Gammal AT; Brüchmann M; Zustin J; Isbarn H; Hellwinkel OJ; Köllermann J; Sauter G; Simon R; Wilczak W; Schwarz J; Bokemeyer C; Brümmendorf TH; Izbicki JR; Yekebas E; Fisch M; Huland H; Graefen M; Schlomm T
    Clin Cancer Res; 2010 Jan; 16(1):56-64. PubMed ID: 20028754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rate of Phosphatase and Tensin (PTEN) Gene Expression Loss in Prostate Cancer and its Link to Tumor Upgrading.
    Gharib A; Aziminejad A; Pourmotahari F; Kazeminejad B; Soleimani M
    Urol J; 2023 Dec; 20(6):403-407. PubMed ID: 36840446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of MYC/PTEN Status by Gene-Protein Assay in Grade Group 2 Prostate Biopsies.
    Salles DC; Vidotto T; Faisal FA; Tosoian JJ; Guedes LB; Muranyi A; Bai I; Singh S; Yan D; Shanmugam K; Lotan TL
    J Mol Diagn; 2021 Aug; 23(8):1030-1041. PubMed ID: 34062284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between chromosome 8 alterations and Gleason score in prostatic adenocarcinoma].
    Zeng X; Wu SF; Xu Q; Xiao Y; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):523-8. PubMed ID: 17134545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal progression of prostate cancers from Gleason grade 3 to grade 4.
    Sowalsky AG; Ye H; Bubley GJ; Balk SP
    Cancer Res; 2013 Feb; 73(3):1050-5. PubMed ID: 23204237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma).
    Shah RB; Shore KT; Yoon J; Mendrinos S; McKenney JK; Tian W
    Prostate; 2019 Aug; 79(11):1267-1273. PubMed ID: 31111513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of PTEN deletion and 16p13.3 gain in prostate cancer provides additional prognostic information in patients treated with radical prostatectomy.
    Bramhecha YM; Rouzbeh S; Guérard KP; Scarlata E; Brimo F; Chevalier S; Hamel L; Aprikian AG; Lapointe J
    Mod Pathol; 2019 Jan; 32(1):128-138. PubMed ID: 30140035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Array-based genomic analysis of screen-detected Gleason score 6 and 7 prostatic adenocarcinomas.
    Postma R; van Marion R; van Duin M; Vissers KJ; Wink JC; Schröder FH; Tanke HJ; Szuhai K; van der Kwast TH; van Dekken H
    Anticancer Res; 2006; 26(2A):1193-200. PubMed ID: 16619524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of PTEN Expression Detected by Fluorescence Immunohistochemistry Predicts Lethal Prostate Cancer in Men Treated with Prostatectomy.
    Hamid AA; Gray KP; Huang Y; Bowden M; Pomerantz M; Loda M; Sweeney CJ
    Eur Urol Oncol; 2019 Sep; 2(5):475-482. PubMed ID: 31411988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN loss and p27 loss differ among morphologic patterns of prostate cancer, including cribriform.
    Ronen S; Abbott DW; Kravtsov O; Abdelkader A; Xu Y; Banerjee A; Iczkowski KA
    Hum Pathol; 2017 Jul; 65():85-91. PubMed ID: 28504208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J; Jenkins RB; Bostwick DG
    Mod Pathol; 1997 Nov; 10(11):1113-9. PubMed ID: 9388062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.